Inactivation of SARS‐CoV‐2 and HCoV‐229E in vitro by ColdZyme® a medical device mouth spray against the common cold

BACKGROUND: The coronavirus disease 2019 (COVID‐19) pandemic calls for effective and safe treatments. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causing COVID‐19 actively replicates in the throat, unlike SARS‐CoV, and shows high pharyngeal viral shedding even in patients with mild...

Descripción completa

Detalles Bibliográficos
Autores principales: Gudmundsdottir, Ágústa, Scheving, Reynir, Lindberg, Fredrik, Stefansson, Bjarki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537187/
https://www.ncbi.nlm.nih.gov/pubmed/32975843
http://dx.doi.org/10.1002/jmv.26554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537187/
https://www.ncbi.nlm.nih.gov/pubmed/32975843
http://dx.doi.org/10.1002/jmv.26554

Ejemplares similares